Role of Interleukin-1β Converting Enzyme (ICE) in Acute Myelogenous Leukemia Cell Proliferation and Programmed Cell Death

References

• Clark S. C., Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229–1237
   PubMed Web of Science ®Google Scholar
• Estrov Z., Kurzrock R., Estey E., Wetzler M., Ferrajoli A., Harris D., Blake M., Gutterman J. U., Talpaz M. Inhibition of acute myelogenous leukemia blast proliferation by IL-1 receptor antagonist and soluble IL-1 receptors. Blood 1992; 79: 1938–1945
   PubMed Web of Science ®Google Scholar
• Hoang T., Hamman A., Goncalves O., Letendre F., Mathieu M., Wong G. G., Clark C. S. Interleukin-1 enhances growth factor-dependent proliferation of the clonogenic cells in acute myeloblastic leukemia and of normal human primitive hematopoietic precursors. J. Exp. Med. 1988; 168: 463–474
   PubMed Web of Science ®Google Scholar
• Zucali J. R., Broxmeyer H. E., Dinarello C. A., Gross M. A., Weiner R. S. Regulation of early human hematopoietic (BFU-E and CFU-GEMM) progenitor cells in vitro by interleukin-1 induced fibroblast medium. Blood 1987; 69: 3–37
   Web of Science ®Google Scholar
• Carter A., Silvian-Draxler I., Tatarsky I. Effect in interleukin-1, tumor necrosis factor-α, and interferon-alpha on the blast cells of acute myeloblastic leukemia. Am. J. Hematol. 1992; 40: 245–251
   PubMed Web of Science ®Google Scholar
• Oster W., Cicco N. A., Klein H., Hirano T., Kishimoto T., Lindmann A., Mertelsmann R. H., Herman F. Participation of the cytokines interleukin-6, tumor necrosis factor-alpha, and interleukin-1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J. Clin. Invest. 1989; 84: 454–457
   Web of Science ®Google Scholar
• Bagby G. C., Dinarello C. A., Wallace P., Wagner C., Hefeneider S., McCall E. Interleukin-1 stimulates GM-CSF release by vascular endothelial cells. J. Clin. Invest. 1986; 78: 1316–1323
   PubMed Web of Science ®Google Scholar
• Herrmann F., Oster W., Meuer S. C., Lindemann A., Mertelsmann R. H. Interleukin-1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor. J. Clin. Invest. 1988; 81: 1415–1418
   PubMed Web of Science ®Google Scholar
• Zucali J. R., Dinarello C. A., Oblon D. J., Gross M. A., Anderson L., Weiner R. S. Interleukin-1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E. J. Clin. Invest. 1986; 77: 857–1863
   Web of Science ®Google Scholar
• Griffin J. D., Rambaldi A., Vellenga E., Young D., Ostapovicz D., Cannistra S. A. Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony-stimulating factors. Blood 1987; 70: 1218–1221
   PubMed Web of Science ®Google Scholar
• Rennick D. G., Yang L., Gemmell L., Lee F. Control of hemopoiesis by a bone marrow stromal cell clone. Lipopolysaccharide and interleukin-1 inducible production of colony-stimulating factors. Blood 1987; 69: 682–691
   PubMed Web of Science ®Google Scholar
• Bartelmez S. H., Bardley T. R., Bertoncello I., Mochizuki D. Y., Tushinski R. J., Stanley E. R., Hapel A. J., Young I. G., Kriegler A. B., Hodgson G. S. Interleukin-1 plus interleukin-3 plus colony-stimulating factor-1 are essential for clonal proliferation of primitive myeloid bone marrow cells. Exp. Hematol. 1987; 17: 240–254
   Web of Science ®Google Scholar
• Stanley E. R., Bartocci A., Partinkin D., Rosendaal M., Bradley T. R. Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1. Cell 1986; 45: 667–674
   PubMed Web of Science ®Google Scholar
• Zsebo K. M., Wypych J., Yuschenkoff V. N., Lu H., Hunt P., Dukes P. P., Langley K. E. Effects of hematopoietin-1 and interleukin-1 activities on early hematopoietic cells of the bone marrow. Blood 1988; 71: 962–968
   PubMed Web of Science ®Google Scholar
• Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627–1652
   PubMed Web of Science ®Google Scholar
• di Giovine F. S., Duff G. W. Interleukin-1: The first interleukin. Immunol. Today 1990; 11: 13–20
   PubMedGoogle Scholar
• Sachs L., Lotem J. Control of programmed cell death in normal and leukemic cells: New implications for therapy. Blood 1993; 82: 15–21
   PubMed Web of Science ®Google Scholar
• Raza A., Preisler H. D., Li Y. Q., Larson R. A., Goldberg J., Browman G., Bennet J., Grunwald H., Vogler R., Kukla C. Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemia. Am. J. Hematol. 1993; 42: 359–366
   PubMed Web of Science ®Google Scholar
• Estrov Z., Kurzrock R., Talpaz M. Cytokines and their antagonists in myeloid disorders. Semin. Hematol. 1995; 32: 220–231
   PubMed Web of Science ®Google Scholar
• Estrov Z., Kurzrock R., Talpaz M. Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia. Leuk. Lymphoma 1993; 10: 407–418
   PubMed Web of Science ®Google Scholar
• Arend W. P. Interleukin-1 receptor antagonist. Adv. Immunol. 1993; 54: 167–227
   PubMed Web of Science ®Google Scholar
• Dower S. K., Wignall J. M., Schooley K., McMahan C. J., Jackson J. L., Prickett K. S., Lupton S., Cosman D., Sims J. E. Retention of ligand binding activity by the extracellular domain of the IL-1 receptor. J. Immunol. 1989; 142: 4314–4320
   PubMed Web of Science ®Google Scholar
• Zheng H., Fletcher D., Kozak W., Jiang M., Hoffman K. J., Conn C. A., Soszynski D., Grabiec C., Trumbauer M. E., Shaw A., Kostura M. J., Stevens K., Rosen H., North R. J., Chen H. Y., Tocci M. J., Kluger M. J., Van der Ploeg L. H. T. Resistance to fever induction and impaired acute-phase reaction in interleukin-1 beta-deficient mice. Immunity 1995; 3: 9–19
   PubMed Web of Science ®Google Scholar
• Mosley B., Urdal D. L., Prickett K. S., Larsen A., Cosman D., Conlon P. J., Gillis S., Dower S. K. The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J. Biol. Chem. 1987; 262: 2941–2944
   PubMed Web of Science ®Google Scholar
• Lonnemann G., Endres S., Van der Meer J. W. M., Cannon J. G., Ghorbani R., Dempsey R. A., Sisson S. D., Wolff S. M., Dinarello C. A. In vitro production of IL 1β IL 1α, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur. J. Immunol. 1989; 19: 2327–2333
   PubMed Web of Science ®Google Scholar
• Limjuco G., Galuska S., Chin J., Cameron P., Boger J., Schmidt F. A. Antibodies of predetermined specificity to the major charged species of human interleukin 1. Proc. Natl. Acad. Sci. USA 1986; 83: 3972–3976
   PubMed Web of Science ®Google Scholar
• Beuscher H. U., Nickells M. W., Colter H. R. The precursor of interleukin-1 alpha is phosphorylated at residue serine 90. J. Biol. Chem. 1988; 263: 4023–4028
   PubMed Web of Science ®Google Scholar
• Kobayashi Y., Appella E., Yamada M., Copeland T. D., Oppenheim J. J., Matsushima K. Phosphorylation of intracellular precursors of human IL-1. J. Immunol. 1988; 140: 2279–2287
   PubMed Web of Science ®Google Scholar
• Schmidt J. A., Tocci M. J. The Handbook of Experimental Pharmacology I. Peptide Growth Factors and Their Receptors, M Sporn, A Roberts. Springer Verlag, BerlinGermany 1990; 473–521
   Google Scholar
• Kobayashi Y., Yamamoto Y. K., Saido T., Kawasaki H., Oppenheim J. J., Matsushima K. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc. Natl. Acd. Sci. USA 1990; 87: 5548–5552
   PubMed Web of Science ®Google Scholar
• Camron P. M., Limjuco G. A., Chin J., Silverstein L., Schmidt J. A. Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1. J. Exp. Med. 1986; 164: 237–250
   PubMed Web of Science ®Google Scholar
• Kostura M. J., Tocci M. J., Limjuxo G., Chin J., Comeron P., Hillman A. G., Chartrain N. A., Schmidt J. A. Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc. Natl. Acad. Sci. USA 1989; 86: 5227–5231
   PubMed Web of Science ®Google Scholar
• Howard A. D., Kostura M. J., Thornberry N., Ding G. J. F., Limjuco G., Weidner J., Salley J. P., Hogouist K. A., Chaplin D. D., Mumford R. A., Schmidt J. A., Tocci M. J. IL-1 converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and dose not cleave 31-kDa IL-1 alpha. J. Immunol. 1991; 147: 2964–2969
   PubMed Web of Science ®Google Scholar
• Black R. A., Kronheim S. R., Cantrell M., Defley M. C., March C. J., Pickett K. S., Wignall J., Conlon P. J., Cosman D., Hopp T. P., Mochizuki D. Y. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J. Biol. Chem. 1988; 263: 9437–9442
   PubMed Web of Science ®Google Scholar
• Black R. A., Kronheim S. R., Sleath P. R. Activation of interleukin-1 beta by a co-induced protease. FEBS Lett. 1989; 247: 386–390
   PubMed Web of Science ®Google Scholar
• Sleath P. R., Hendrickson R. C., Kronheim S. R., March C. J., Black R. A. Substrate specificity of the protease that processes human interleukin-1 beta. J. Biol. Chem. 1990; 265: 14526–14528
   PubMed Web of Science ®Google Scholar
• Thornberry N. A., Bull H. G., Calaycay J. R., Chapman K. T., Howard A. D., Kostura M. J., Miller D. K., Molineaux S. M., Weidner J. R., Aunins J., Elliston K. O., Ayala J. M., Casano R. J., Chin J., Ding G. J. F., Egger L. A., Gaffney D. P., Limjuco G., Palyha O. C., Raju S. M., Rolando A. M., Salley J. P., Yamin T. T., Lee T. D., Shively J. E., MacCoss M., Mumford R. A., Schmidt J. A., Tocci M. J. A novel heterodimeric cysteine protease is required for interleukin-1 β processing in monocytes. Nature 1992; 356: 768–774
   PubMed Web of Science ®Google Scholar
• Cerreti D. P., Koslosky C. J., Mosley B., Nelson N., Van Ness K., Greenstreet T. A., March C. J., Kronheim S. R., Druck T., Cannizzarro L. A., Huebner K., Black R. A. Molecular cloning of the interleukin-1 β converting enzyme. Science 1992; 256: 97–100
   PubMed Web of Science ®Google Scholar
• Singer I. I., Scott S., Chin J., Bayne E. K., Limjuco G., Weidner J., Miller D. K., Chapman K., Kostura M. J. The interleukin-1 β-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J. Exp. Med. 1995; 182: 1447–1459
   PubMed Web of Science ®Google Scholar
• Walker N. P. C., Talanian R. V., Brady K. D., Dang L. C., Bump N. J., Ferenz C. R., Franklin S., Ghayur T., Hackett M. C., Hammill L. C., Herzog L., Hugunin M., Houy W., Markovich J. A., McGuiness L., Orlewicz E., Paskind M., Pratt C. A., Reis P., Summani A., Terranova M., Welch J. P., Xiong L., Moller A., Tracey D. E., Kamen R., Wong W. W. Crystal structure of the cysteine protease interleukin-1β converting enzyme: A (p20/p10)2 homodimer. Cell 1994; 78: 343–352
   PubMed Web of Science ®Google Scholar
• Wilson K. P., Black J. F., Thomson J. A., Kim E. E., Griffith J. P., Navia M. A., Murcko M. A., Chambers S. P., Aldape R. A., Raybuck S. A., Livingston D. J. Structure and mechanism of interleukin-1β converting enzyme. Nature 1994; 370: 270–275
   PubMed Web of Science ®Google Scholar
• Gu Y., Wu J., Faucheu C., Lalanne J. L., Diu A., Livingston D. J., Su M. S. Interleukin-1 beta converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J. 1995; 14: 1923–1931
   PubMed Web of Science ®Google Scholar
• Miller D. K., Ayala J. M., Egger L. A., Raju S. M., Yamin T. T., Ding G. J. P., Gaffney E. P., Howard A. D., Palyha O. C., Rolando A. M., Salley J. P., Thornberry N. A., Weidner J. R., Williams J. H., Chapman K. T., Jackson J., Kostura M. J., Limjuco G., Molineaux S. M., Mumford R. A., Calaycay J. R. Purification and characterization of active human interleukin-1β converting enzyme from THP. 1 monocytic cells. J. Biol. Chem. 1993; 268: 18062–18069
   PubMed Web of Science ®Google Scholar
• Thornberry N. A., Molineaux S. M. Interleukin-1β converting enzyme: A novel cysteine protease required for IL-1β production and implicated in programmed cell death. Protein Science 1995; 4: 3–12
   PubMed Web of Science ®Google Scholar
• March C. J., Mosle B., Larsen A., Cerretti P., Braedt G., Price V., Gillis S., Henney C. S., Kronheim S. R., Grabstein K., Conlon P. J., Hopp T. P., Cosman D. Cloning sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 1985; 315: 641–647
   PubMed Web of Science ®Google Scholar
• Singer I. I., Scott S., Hall G. L., Limjuco G., Chin J., Schmidt J. A. Interleukin 1β is localized in the cytoplasmic ground substance but is largely absent from the golgi apparatus and plasma membranes of stimulated human monocytes. J. Exp. Med. 1988; 167: 389–407
   PubMed Web of Science ®Google Scholar
• Rubartelli A., Cozzolino F., Talio M., Sitia R. A novel secretory pathway for interleukin-1β, a protein lacking a signal sequence. EMBO J. 1990; 9: 1503–1510
   PubMed Web of Science ®Google Scholar
• Hazuda D. J., Lee J. C., Young P. R. The kinetics of interleukin 1 secretion from activated monocytes. J. Biol. Chem. 1988; 263: 8473–8479
   PubMed Web of Science ®Google Scholar
• Yuan J., Shaham S., Ledoux S., Ellis H. M., Horvitz H. R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta converting enzyme. Cell 1993; 75: 641–652
   PubMed Web of Science ®Google Scholar
• Miura M., Zhu H., Rotello R., Hartwieg E. A., Yuan J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of C. elegans cell death gene. ced-3. Cell 1993; 75, 653–660
   Google Scholar
• Ray C. A., Black R. A., Kronheim S. R., Greenstreet T. A., Sleath P. R., Salvesen G. S., Pickup D.J. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 β converting enzyme. Cell 1992; 69: 597–604
   PubMed Web of Science ®Google Scholar
• Palumbo G. J., Pickup D. J., Fredrickson T. N., McIntyre L. J., Buller M. L. Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox. Virology 1989; 172: 262–273
   PubMed Web of Science ®Google Scholar
• Gagliardini V., Fernandez P.-A., Lee R. K. K., Drexler H. C. A., Rotello R. J., Fishman M. C., Yuan J. Prevention of vertebrate neuronal death by the crmA gene. Science 1994; 263: 826–828
   PubMed Web of Science ®Google Scholar
• Boudreau N., Sympson C. J., Werb Z., Bissell M. J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995; 267: 891–893
   PubMed Web of Science ®Google Scholar
• Nagata S., Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 1995; 16: 39–43
   PubMedGoogle Scholar
• Tewari M., Dixit V. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the Poxvirus crmA gene product. J. Biol. Chem. 1995; 270: 3255–3260
   PubMed Web of Science ®Google Scholar
• Enarl M., Hug H., Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995; 375: 78–81
   PubMed Web of Science ®Google Scholar
• Los M., Van de Craen M., Penning L. C., Schenk H., Westendorp M., Baeuerie P. A., Droge W., Krammer P. H., Flers W., Schulze-Osthoff K. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 1995; 375: 81–83
   PubMed Web of Science ®Google Scholar
• Tamura T., Ishikhara M., Lamphier M. S., Tanaka N., Oishi I., Alzawa S., Matsuyama T., Mak T. W., Taki S., Taniguchi T. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 1995; 376: 596–599
   PubMed Web of Science ®Google Scholar
• Hengartner M. O., Ellis R. E., Horvitz H. R. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 1992; 356: 494–499
   PubMed Web of Science ®Google Scholar
• Hengartner M. O., Horvitz H. R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene. bcl-2. Cell 1994; 76, 665–676
   Google Scholar
• Tsujimoto Y., Cossman J., Jaffe E., Croce C. M. The t(14;18) chromosome translocation involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985; 228: 1440–1443
   PubMed Web of Science ®Google Scholar
• Bakhshi A., Jensen J. P., Goldman P., Wright J. J., McBride O. W., Einstein A. L., Korsmeyer S. J. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit of 18. Cell 1985; 41: 899–906
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Smith S. D., Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986; 47: 19–28
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J. Regulators of cell death. Trends Genet 1995; 11: 101–105
   PubMed Web of Science ®Google Scholar
• Hengartner M. O., Horvitz H. R. Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in Bcl-2. Nature 1994; 369: 318–320
   PubMed Web of Science ®Google Scholar
• Vaux D. L., Weissman I. L., Kim S. K. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 1992; 258: 1955–1957
   PubMed Web of Science ®Google Scholar
• Lazebnik Y. A., Kaufmann S. H., Desnoyers S., Poirier G. G., Earnshaw W. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346–347
   PubMed Web of Science ®Google Scholar
• Gu Y., Sarnecki C., Aladape R. A., Livingston D. J., Su M. S. Cleavage of poly(ADP-dibose) polymerase by interleukin-1 β converting enzyme and its homologs TX and Need-2. J. Biol. Chem. 1995; 270: 18715–18718
   PubMed Web of Science ®Google Scholar
• Wang L., Miura M., Bergerson L., Zhu H., Yuan J. Ich-1, an Ice/ced-related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994; 78: 739–750
   PubMed Web of Science ®Google Scholar
• Kumar S., Kinoshita M., Noda M., Copeland N. G., Jenkins N. A. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditits elegans cell death gene ced-3 and the mammalian II-1β-converting enzyme. Genes Dev. 1994; 8: 1613–1626
   PubMed Web of Science ®Google Scholar
• Darmon A. J., Nicholson D. W., Bleackley R. C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995; 377: 446–448
   PubMed Web of Science ®Google Scholar
• Nicholson D. W., Ali A., Thornberry N. A., Vaillancourt J. P., King C. K., Gallant M., Gareau Y., Griffin P. R., Labelle M., Lazebnik Y. A., Munday N. A., Raju S. M., Smulson M. E., Yamin T. T., Yu V. L., Miller D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 375: 37–43
   Web of Science ®Google Scholar
• Fernandes-Alnemri T., Litwack G., Alnemri E. S. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J. Biol. Chem. 1994; 269: 30761–30764
   PubMed Web of Science ®Google Scholar
• Smulson M., Istock N., Ding R., Cherney B. Deletion mutants of poly(ADP-ribose) polymerase support a model of cyclic association and dissociation of enzyme from DNA ends during DNA repair. Biochemistry 1994; 33: 6186–6191
   PubMed Web of Science ®Google Scholar
• Ding R., Smulson M. Depletion of nuclear poly(ADP-ribose) polymerase by antisense RNA expression: influences on genomic stability, chromatin organization, and carcinogen cytotoxicity. Cancer Res. 1994; 54: 4627–4634
   PubMed Web of Science ®Google Scholar
• Kaufmann S. H., Desnoyers S., Ottaviano Y., Davidson N. E., Poirer G. G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res. 1993; 53: 3976–3985
   PubMed Web of Science ®Google Scholar
• Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D. R., Poirier G. G., Salvesen G. S., Dixit V. M. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81: 801–809
   PubMed Web of Science ®Google Scholar
• Munday N. A., Vaillancourt J. P., Ali A., Casano F. J., Miller D. K., Molineaux S. M., Yamin T.-T., Yu V. L., Nicholson D. W. Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, Members of the ICE/CED-3 family of cysteine proteases. J. Biol. Chem. 1995; 270: 15870–15876
   PubMed Web of Science ®Google Scholar
• Faucheu C., Diu A., Chan A. W., Blancht A. M., Missec C., Here F., Collard-Dutilleul V., Gu Y., Aldape R. V., Lippke J. A., Rocher C., Su M. S., Livingston D. J., Hercend T., Lalanne J. L. A novel human proteinase similar to the interleukin-1 β converting enzyme induces apoptosis in transfected cells. EMBO J. 1995; 14: 1914–1922
   PubMed Web of Science ®Google Scholar
• Kamens J., Paskind M., Hugunin M., Talanian R. V., Allen H., Banach D., Bump N., Hackett M., Johnston C. G., Li P., Mankovich J. A., Terranova M., Ghayur T. Identification and characterization of ICH-2, a novel memeber of the interleukin-1 beta-converting enzyme family of cysteine proteases. J. Biol. Chem. 1995; 270: 15250–15256
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T., Litwack G., Alnemri E. S. McH2, a new member of the apoptotic Ced-3/Ice Cysteine protease gene family. Cancer Res. 1995; 55: 2737–2742
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T., Takahashi A., Armstrong R., Krebs J., Fritz L., Tomaselli K. J., Wang L., Yu Z., Croce C. M., Salveson G., Ernshaw W. C., Litwack G., Alnemri E. S. McH3, a novel human apoptosis protease highly related to CPP32. Cancer Res. 1995; 55: 6045–6052
   PubMed Web of Science ®Google Scholar
• Duan H., Chinnaiyan A. M., Hudson P. L., Wing J. P., He W.-W., Dixit V. M. ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 1996; 271: 1621–1625
   PubMed Web of Science ®Google Scholar
• Chinnaiyan A. M., Orth K., O'Rourke K., Duan H., Poirer G. G., Dixit V. M. Molecular ordering of the cell death pathway: Bcl-2 and Bcl-x function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem., in press
   Web of Science ®Google Scholar
• Wang X., Pai J. T., Wiedenfeld E. A., Medina J. C., Slaughter C. A. Purification of an interleukin-1 beta converting enzyme-related cysteine protease that cleaves sterol regulatory element-binding proteins between the leucine zipper and transmembrane domains. J. Biol. Chem. 1995; 270: 18044–18050
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T., Litwack G., Alnemri E. S. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J. Biol. Chem. 1994; 269: 30761–30764
   PubMed Web of Science ®Google Scholar
• Kumar S., Harvey N. L. Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett. 1995; 375: 169–173
   PubMed Web of Science ®Google Scholar
• Young J. O.-E. Killing of target cells by lymphocytes: a mechanistic view. Physiol. Rev. 1989; 69: 250–314
   PubMed Web of Science ®Google Scholar
• Berke G. The CTL's kiss of death. Cell 1995; 81: 9–12
   PubMed Web of Science ®Google Scholar
• Jenne D. E., Tschopp J. Granzymes: A family of serine proteases in granules of cytolytic T lymphocytes. Curr. Top. Microbiol. Immunol. 1988; 140: 33–47
   Web of Science ®Google Scholar
• Smyth M. J., Trapani J. A. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol. Today 1995; 16: 202–206
   PubMedGoogle Scholar
• Berthou C., Marolleau J. P., LaFaurie C., Soulie A., Dal Cortivo L., Bourge J.-F., Benbunan M., Sesportes M. Granzyme B and perforin lytic proteins are expressed in CD34+ peripheral blood progenitor cells mobilized by chemotherapy and grandlocyte colony-stimulating factor. Blood 1995; 86: 3500–3506
   PubMed Web of Science ®Google Scholar
• Irmler M., Hertig S., Robson M., Sadoul R., Becherer J. D., Proudfoot A., Solari R., Tschopp J. Granzyme A is as interleukin-1 β-converting enzyme. J. Exp. Med. 1995; 181: 1917–1922
   PubMed Web of Science ®Google Scholar
• Xue D., Horvitz R. Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a Ced-3 cleavage site in baculovirus p35 protein. Nature 1995; 377: 248–251
   PubMed Web of Science ®Google Scholar
• Wang Z. O., Auer B., Stingl L., Berghammer H., Haidacher D., Schweiger M., Wagner E. F. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 1995; 9: 509–20
   PubMed Web of Science ®Google Scholar
• Lazebnik Y. A., Takahashi A., Moir R. D., Goldman R. D., Poirier G. G., Kaufmann S. H., Earnshaw W. C. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA 1995; 92: 9042–9046
   PubMed Web of Science ®Google Scholar
• Pushkareva M., Obeid L. M., Hannun Y. A. Ceramid: an endogenous regulator of apoptosis and growth suppression. Immunol. Today 1995; 16: 294–297
   PubMedGoogle Scholar
• Kolesnick R. N., Haimovitz-Freedman A., Fuks Z. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor. Fas. and ionizing radiation. Biochem. Cell Biol. 1994; 72: 471–474
   PubMed Web of Science ®Google Scholar
• Chinnaiyan A. M., Tepper C. G., Seldin M. F., O'Rourke K., Kischkel F. C., Hellbardt S., Krammer P. H., Peter M. E., Dixit V. M. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1)- and TNF-receptor-induced apoptosis. J. Biol. Chem., in press
   Google Scholar
• Li P., Allen H., Banerjee S., Franklin S., Herzog L., McDowell J., Paskind M., Rodman L., Salfeled J., Towne E., Tracey D., Wardwell S., Wet F.-Y., Wong W., Kamen R., Seshardi T. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 1995; 80: 401–411
   PubMed Web of Science ®Google Scholar
• Kuida K., Lippke J. A., Ku G., Harding M. W., Livingston D. J., Su M. S., Flavell R. A. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 1995; 267: 2000–2003
   PubMed Web of Science ®Google Scholar
• Komiyama T., Ray C. A., Pickup D. J., Howard A. D., Thornberry N. A., Peterson E. P., Salvesen G. Inhibition of interleukin-1β converting enzyme by the cowpox virus serpin crmA. J. Biol. Chem. 1994; 269: 19331–19337
   PubMed Web of Science ®Google Scholar
• Clem R. J., Fechheimer M., Miller L. K. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 1991; 254: 1388–1390
   PubMed Web of Science ®Google Scholar
• Sugimoto A., Friesen P. D., Rothman J. H. Baculovirus p35 prevents developmentally programmed cell death and rescues a ced-9 mutant in the nematode. Caenorhabditis elegans. EMBO J 1994; 13, 2023–2028
   Google Scholar
• Shaw E. Cysteinyl proteinases and their selective inactivation. Adv. Enzymol. 1990; 63: 271–347
   PubMedGoogle Scholar
• Miller B. E., Krasney P. A., Gauvin D. M., Holbrook K. B., Koonz D. J., Abruzzese R. V., Miller R. V., Pagani Ka, Dole R. E., Ator M. A., Gilman S. C. Inhibition of mature IL-1β production in mature macrophages and a murine model of inflammation by WIN 67694, an inhibitor of IL-1β converting enzyme. J. Immunol. 1995; 154: 1331–1338
   PubMed Web of Science ®Google Scholar
• Robinson R. P., Donahue K. M. Synthesis of a peptidyl difluoro ketone bearing the aspartic acid side chain: An inhibitor of interleukin-1β converting enzyme. J. Org. Chem. 1992; 57: 7309–7314
   Web of Science ®Google Scholar
• Rambaldi A., Torcia M., Bettoni S., Vannier E., Barbui T., Shaw A. R., Dinarello C. A., Cozzolino F. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood 1991; 78: 3248–3253
   PubMed Web of Science ®Google Scholar
• Yin M., Gopal V., Banavali S., Gartside P., Preisler H. Effect of an IL-1 receptor antagonist on acute myeloid leukemia cells. Leukemia 1992; 6: 898–901
   PubMed Web of Science ®Google Scholar
• Estrov Z., Black R., Sleath P. R., Harris D., Van Q., LaPushin R., Estey E., Talpaz M. Effect of interleukin-1 β converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation. Blood 1995; 86: 4594–4602
   PubMed Web of Science ®Google Scholar
• Kettner C., Shaw E. Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone. Methods in Enzymology. Vol. 80, Proteolytic Enzymes. Part C, L. Lorand. Academic Press Inc, Orland FL 1989; 826–842, 826842
   Google Scholar
• Stosic-Grujcic S., Basara N., Milenkovic P., Dimarello C.A. Modulation of acute myeloblastic leukemia (AML) cell proliferation and blast colony formation by anti-sense oligomer for IL-1 beta converting enzyme (ICE) and IL-1 receptor antagonist (IL-lra). J. Chemother 1995; 7: 67–70
   Web of Science ®Google Scholar